FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways

Ann Transl Med. 2020 Apr;8(7):511. doi: 10.21037/atm.2020.01.21.

Authors

Cara A Rabik^{1

2}, Jiawan Wang^{1

2}, Christine A Pratilas^{1

2}

Affiliations

¹ Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
² Johns Hopkins University School of Medicine, Baltimore, MD, USA.

No abstract available

Publication types

Editorial
Comment